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resumo 
 
 
O cádmio exerce efeitos nocivos para a saúde pública. A exposição ambiental 
e ocupacional, são as duas principais formas de exposição em humanos. Foi 
também demonstrado que mesmo baixos níveis de exposição ao cádmio 
podem causar falência de diferentes órgãos. A exposição ao cádmio está 
também associada a doenças relacionadas com o tecido ósseo. Além disso, foi 
relatado que a exposição ao cádmio pode perturbar a homeostasia do cálcio, 
formação de vitamina D e é também capaz de interagir directamente no 
metabolismo ósseo.  
As espécies reactivas de oxigénio têm uma função importante na reabsorção 
óssea e, desta forma, a ruptura do equilíbrio oxidativo pode resultar em 
distúrbios no seu metabolismo. Embora os efeitos deletérios do cádmio no 
osso sejam conhecidos, os mecanismos de acção nas células ósseas ainda 
não estão completamente esclarecidos. 
Os objectivos deste estudo consistiram em avaliar o papel do cádmio na 
promoção de alterações celulares, tais como desequilíbrio oxidativo e indução 
de apoptose. 
Para investigar os efeitos do cádmio foi utilizada a linha humana de 
osteosarcoma MG-63. A inibição da viabilidade celular pelo cádmio foi avaliada 
através do ensaio de MTT. Com base nesses resultados foram escolhidos as 
doses subletais de cádmio (20 e 50 µM) a serem utilizadas nos estudos 
posteriores. As células foram expostas às duas concentrações de cádmio em 
dois períodos de tempo (24 e 48 horas). Os seus efeitos citotóxicos foram 
avaliados vários por parâmetros enzimáticos de stress 
oxidativo,nomeadamente a determinação da actividade de superóxido 
dismutase, catalase e a glutationa reductase assim como conteúdo total de 
glutationa . Além destes, foi também avaliada a indução da apoptose pelo 
cádmio, através do ensaio com anexina V. 
Observaram-se diferenças em todas as enzimas anti-oxidantes, 
nomeadamente, um aumento da actividade catalase com o aumento da dose 
de cádmio e uma inibição da actividade da glutationa reductase assim como da 
concentração de glutationa, resultando em stress oxidativo. Finalmente, 
observou-se que nas doses e tempos testados, o cádmio induziu apoptose nas 
células. 
Em conclusão, o cádmio, nas concentrações de 20 µM e 50 µM induziu 
alterações na fisiologia da linha celular humana MG-63, causando stress 
oxidativo levando à morte celular por apoptose. 
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abstract 
 
Cadmium exerts harmful effect on public health. Environmental and 
occupational exposure, are the two main ways for human exposure. It was also  
shown that even low levels of cadmium exposure can leave to renal and other 
organs failure. Exposure to cadmium is associated with various bone problems 
and diseases like bone loss, fragilization and osteoporosis. Moreover, it was 
reported that cadmium exposure may perturb calcium homeostasis, Vitamin D 
formation and interact directly on bone metabolism.  
Reactive oxygen species have an important function in bone resorption, so 
disruption of the oxidative balance in bone tissue may result in disorders in 
bone metabolism. Although the deleterious effects of cadmium in bone are 
known, the mechanisms of action in bone cell are still not completely 
understood. 
The aims of this research study were to evaluate cadmium role in promoting 
cellular alterations, namely inducing oxidative stress imbalance and ultimately 
apoptosis. 
To investigate cadmium effects the human osteoblast-like cell line MG-63 was 
used. Inhibition of cell viability by cadmium was assessed by MTT assay. 
Based on these results, the sublethal doses of cadmium, 20 and 50 μM were 
chosen, for further studies. Cells were exposed to those concentrations of 
cadmium chloride for two periods of time (24 and 48 hours). After that, cells 
were harvested and several parameters were evaluated. The cytotoxic 
parameters followed a comprehensive set of oxidative stress assays with 
enzymatic parameters, namely determination of the activity of superoxide 
dismutase, catalase glutathione reductase and total glutathione content. 
Moreover, cadmium-induced apoptosis was assessed with annexin V assay. 
We observed differences in all anti-oxidant enzymes, namely an increase, 
catalase activities with the increased of cadmium dose and a glutathione 
reductase activity inhibition and also depletion on glutathione content, which 
may result in imbalance in oxidative stress. Finally, for the doses and periods 
tested, cadmium induced cell apoptosis..  
In conclusion, cadmium chloride at 20 µM and 50 µM induced changes on 
human MG-63 cell line physiology, as it cause oxidative stress imbalance which 
lead to cell death by apoptosis.  
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Introduction 
1. CADMIUM: GENERAL CONSIDERATIONS  
 Cadmium (Cd) was discovered in XIX century in 1817 by the German chemist 
Friedrich Strohmeyer. It is a natural element in the earth's crust and usually found in 
combination with other elements such as oxygen (cadmium oxide), chlorine (cadmium 
chloride), or sulfur (cadmium sulfate, cadmium sulfide). All soils and rocks, including coal 
and mineral fertilizers, contain some Cd. Most Cd used is extracted during the production 
of other metals like zinc, lead and copper (1). 
 Cd does not corrode easily and has many applications, including the manufacture of 
nickel-cadmium (Ni-Cd) batteries, pigments and plastic stabilizers and also in metal 
coatings, alloys and electroplating. It also has applications in nanotechnology, e.g., in 
cadmium-containing nanoparticles (such as those of CdSe or CdTe), which have numerous 
biomedical applications, especially in the diagnosis of cancer (2-4). Natural sources of Cd 
exposure include volcanic activity, forest fires and soil particles carried by wind. Most 
important anthropic sources are copper (Cu) and nickel (Ni) smelting and fossil fuel 
combustion (5). 
 Cd is nowadays classified as a toxic element without any beneficial role in human 
physiology. It was recently reported that some marine algae contain a form of the enzyme 
carboanhydrase with Cd instead of zinc (Zn) in their active sites (6).  
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1.1. Cadmium as a Health Hazard 
 Cd is an ubiquitous environmental and occupational pollutant. Its first harmful 
effects were discovered only forty years later of its discover, as acute gastrointestinal and 
respiratory problems in persons using cadmium carbonate powder as a polishing agent. 
Soon after 1912, its occupational exposure was augmented with production of Ni-Cd 
batteries in Sweden. Damage in the lungs in Cd-exposed workers was reported early as the 
1930s, later, in the 1940s proteinuria and emphysema was reported and confirmed by 
further investigations on lungs, kidneys, and bones (recently reviewed by Nordberg (7)). It 
was based on Itai-itai disease that the dangerous dimensions of Cd as an environmental 
pollutant were demonstrated. Itai-itai was an endemic bone disease characterized by 
fractures and severe pain related to Cd exposure that occurred after World War II in 
Toyama Prefecture in Japan. By 1968, the Japanese government acknowledged this as an 
environmental disease related to Cd-contaminated water released from a mine into the 
Jinzu River, which was used to irrigate rice fields (7). For the first time, Cd pollution was 
shown to have severe consequences on human health with the demonstration that exposure 
to high Cd levels was associated with adverse effects on the skeleton through toxic effects 
on kidney, and also, as was confirmed later, by direct Cd effects on bone tissue. For all 
that, World Health Organization considers Cd as a highly toxic and a human carcinogen 
causing cancers in lung, prostate, pancreas, and kidney (8). 
1.1.1. Cadmium intake 
 Humans are prone to make contact with Cd either by occupational and non-
ocupational exposure. The routes of its intake involve the lungs, intestines and skin. Cd 
binds predominantly to metallothioneins (9-11). The Cd–metallothionein complex is 
distributed to various tissues and organs and is ultimately reabsorbed in kidney tubuli (10, 
12). There are no known mechanisms for the excretion of Cd in humans, thus it 
accumulates in tissues. The half-life of Cd in kidney cortex is 20–35 years. In humans, the 
largest amount of Cd is deposited in the kidneys, liver, pancreas and lungs (13).  
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1.1.1.1. Occupational exposure 
 Occupational exposure to Cd usually occurs in: mines; production of batteries and 
pigments containing Cd; mineral smelting, Cd production and processing; recycling 
electronic waste and in smoking. In the last few decades, the production and use of Cd had 
a significant drop, especially in the United States of America and in the European Union 
(14). Cd nanoparticles, despite their potential to revolutionize medical therapy, are putative 
toxicants, and their use is therefore likely to become another source of its toxicity in the 
future. However, Cd remains a major health problem, mostly due to its long half-life (15 to 
20 years) and persistence in the environment. It can enter the food chain, increasing Cd 
human availability by bioaccumulation (15).  
1.1.1.2. Non- occupational exposure 
 Food is the main source of Cd for the non-smoking population estimates of dietary 
Cd intake worldwide range from 10–40 μg/day in non-polluted areas to several hundred 
micrograms in Cd-polluted regions (16). Cd is a contaminant present in almost all forms of 
food, with greater incidence to wheat and rice, green leafy vegetables, in potatoes and in 
fish and jellyfish (mollusks and crustaceans). This is due to anthropic activities (as those 
reported above) which contribute in a significantly manner to Cd leakage to food chain by 
the soil and seas contamination. Additionally, the predominant human Cd daily intake 
arrives from smoking. Depending of the brand, each cigarette can contain between 1 μg 
and 2 μg of Cd, which 40% to 60% can reach the blood stream by oral intake (17, 18). 
1.1.2. Cadmium and bone 
 As reported above, the consumption of Cd-contaminated rice and water provoked 
severe problems in Toyama-Japan population. Itai-itai etiology consists in symptoms of 
osteomalacia and osteoporosis, femoral pain, lumbago and skeleton deformations, renal 
tubular dysfunction, immune deficiencies and anaemia. Biochemical findings were 
characteristic of osteomalacia with increased serum levels of alkaline phosphatase and 
decreases in calcium and phosphate levels. Anemia and gastrointestinal and renal 
dysfunction were other less prominent findings (7) 
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 To define the occupational and environmental exposure risks, the Scientific 
Committee on the Toxicology of Metals under the International Commission on 
Occupational Health established some key concepts. One of them is the term, “critical 
organ” which is considered as “that particular organ which first attains the critical 
concentration of a metal under specified circumstances of exposure and for a given 
population”. The “critical organ” is related to the term “critical effect”. The “critical 
effect” is the earliest adverse effect occurring at relatively low exposures when the 
threshold concentration (critical concentration) is reached in the critical organ. The critical 
concentration in the critical organ is the concentration in the organ when adverse 
functional changes, reversible or irreversible, occur in the most sensitive cells of the organ 
(as described by Nordberg (7)). The knowledge of the critical effect is crucial for 
preventive action, because it is the earliest effect occurring at the lowest exposure levels 
(7). 
 During the first half of the last century, damages of lung and kidney were reported 
as the critical effects in occupational exposure to Cd. Researchers initially considered bone 
effects as secondary ones (mediated by kidney effects). The Cd effects on bone thus were 
not considered to be critical effects. At present, it seems more difficult to determine 
whether bone effects may be critical effects or not, because there are indications from 
animal experiments of a direct effect of Cd on bone remodeling, and increased bone loss 
has been demonstrated in Cd exposed animals even before renal dysfunction is developed. 
These data support therefore that Cd has a direct effect on bone mineralization 
(Bhattacharyya vide Gunnar (19)). 
 In the last decade emerging new data arose on Cd toxicity on several tissues/organs 
such as leading to impairment of reproductive system (20) and promoting carcinogenesis 
(see 1.2), among others. Similarly, direct effects of Cd on bone have increasingly come 
into focus supporting them as critical effects. It is, so, imperative to identify Cd model(s) 
of action, which will provide new insight in both: a) Cd and/or Cd-based nanoparticles 
toxicity and b) develop new forms of treatment in case of Cd intoxication. 
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1.2. Cadmium and Cell Biology 
1.2.1. Cadmium as a carcinogen 
 Cd has been classified as a human carcinogen of category #1 by the International 
Agency for Research on Cancer and the National Toxicology Program of the USA (21). It 
has also been suggested that Cd might also be implicated in the pathogenesis of human 
pancreatic cancer and renal carcinoma (22, 23). Occupational exposure to Cd has been 
associated with prostate, lung and gastro-intestinal (kidney and pancreas) cancers. 
Smoking can synergistically increase the carcinogenic effect of Cd (24). The effect of 
environmental exposure to Cd on cancer incidence had shown an association between risk 
of cancer and Cd exposure. A possible cause of Cd induced carcinogenicity may rely on its 
interactions with E-cadherin (a transmembrane Ca(II)-binding glycoprotein playing an 
important role in cell–cell adhesion). This glycoprotein can also bind Cd to Ca(II)-binding 
regions, changing the glycoprotein conformation, and so disrupting cell-cell adhesion and 
eventually becoming a promoter of tumor induction . Cd can also activate cellular protein 
kinases (protein kinase C), which result in enhanced phosphorylation of various 
transcription factors which in turn lead to activation of target gene expression (25). 
 It is well known that Cd also interferes with the biokinetics and biological roles of 
many essential metals and metalloids such calcium (Ca), magnesium (Mg), sodium (Na), 
potassium (K), zinc (Zn), copper (Cu), iron (Fe), manganese (Mn), selenium (Se), 
molybdenum (Mo), trivalent chromium [Cr(III)], cobalt (Co), boron (B), among others 
(26). However, the exact mechanisms involved in these interactions have not been entirely 
identified. Cd and Zn interactions are probably among the most recognized metal-metal 
interactions. This interaction was strongly supported by data that correlated the increasing 
exposure of the population to environmental Cd and an increase of Zn deficiency (15). Zn 
is a co-factor in innumerous enzymes and regulatory proteins, including enzymes for 
synthesis and repair of DNA and RNA. Moreover, because Cd and Zn have similar 
characteristics - both belong to the group 12 of the periodic table and form tetrahedral 
complexes, they compete for the same binding sites and/or ligands in biological systems. 
This interaction causes impairment in Zn homeostasis and may have serious consequences 
on cell growth, development, and their functions. 
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1.2.2. Cadmium and oxidative stress  
 Although the toxic mechanisms of Cd are not fully understood, it’s known that Cd 
acts intracellulary mainly by free radical-induced damage, particularly to the lungs, 
kidneys, bone, central nervous system, reproductive organs and heart (27). Moreover, Cd 
by itself, is unable to generate free radicals directly, indirect formation of reactive oxygen 
species (ROS) and reactive nitrogen species (RNS) involving the superoxide radical, 
hydroxyl radical and nitric oxide has been reported (22). Other authors also described the 
generation of H2O2, induced by Cd which can be a major source of radicals via Fenton 
chemistry. Indeed, Prince proposed in 1983 (28) a mechanisms in which Cd can replace Fe 
and Cu in several cytoplasmic or membrane proteins (e.g., ferritin, apoferritin) thus 
increasing the pool of unbound Fe and Cu ions, which are capable of creating oxidative 
stress via Fenton reactions. These results are also supported by more recent findings on 
Cd-induced displacements of other cations (29) 
 Once inside the cell, Cd may also target mitochondria, mostly by binding to protein 
thiols in mitochondrial membranes. This interaction may influence mitochondrial 
permeability transition, inhibit electron transport chain, and may lead to ROS generation. 
Moreover, Cd inhibits mitochondrial complex III, which lead to semiubiquinone 
accumulation, promoting the transference of electrons to molecular oxygen forming 
superoxide anions. These Cd-mitochondria interactions are in general present in both plant 
and animal cells, and it is evident that this is an important source for Cd generated ROS in 
the cell (30). 
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2. OXIDATIVE STRESS 
 Oxidative stress has been defined as a disturbance in the balance between the 
production of oxidant species (free radicals) and antioxidant defenses, which may lead to 
tissue injury (31). Free radicals are formed in large amounts as an unavoidable by-product 
of many biochemical processes and in some instances, deliberately (e.g. as it happens in 
activated neutrophils). In addition, free radicals may be generated in the body in response 
to electromagnetic and ionizing radiation like X-rays and by gamma rays from the 
environment or acquired directly as oxidizing pollutants such as ozone and nitrogen 
dioxide. At the physiological level they can be produced by metal-catalyzed reactions, by 
neutrophils and macrophages activation during inflammation and by mitochondria (32).  
 As result of free radical generalized attack of cell components, complex antioxidant 
defense mechanisms have evolved to protect body tissues. Despite the presence of this 
antioxidant system, oxidative damage accumulates during the life cycle. Its accumulation 
in DNA, proteins and lipids play a key role in the development of age-dependent diseases 
such as cancer, arteriosclerosis, arthritis, neurodegenerative disorders, among other 
conditions. ROS are also implicated in several signaling pathways, which are well 
harmonized with cell antioxidant network (33) 
2.1. Free Radicals 
 Free radicals are any chemical species with independent existence that contains 
unpaired electrons (32). These electrons increase the chemical reactivity of an atom or 
molecule. The most common examples of free radicals are the hydroxyl radical (
•
OH), 
superoxide anion (
•
O2
-
), transition metals such as iron and copper, nitric oxide (
•
NO) (32). 
 Free radicals can be produced by different biochemical processes within the body 
including: reduction of molecular oxygen during aerobic respiration yielding superoxide 
and hydroxyl radicals in mitochondrial electron transport chain; as a by-products of 
chemistry such as oxidation of catecholamines and activation of the arachidonic acid 
cascade product electrons, which can reduce molecular oxygen to superoxide; in 
cytochrome P450 enzymes metabolism; in, e.g., vascular endothelium that produce nitric 
oxide; or in inflammatory cell activation. In addition, free radicals can be produced 
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physiologically in response to environmental stress agents, e.g. metal ions, electromagnetic 
radiation (13, 23). 
 The presence of unpaired electrons in free radicals confers them highly reactivity, 
although this varies from radical to radical. Free radicals need to achieve a more stable 
state by acceptance or donation of electrons to other molecules. As most molecules are not 
free radicals, the majority of reactions will involve non-radical species. Reactions of a 
radical with a non-radical (all biological macromolecules are possible targets) produce free 
radical chain reactions with the formation of new radicals, which in turn can react with 
further macromolecules. Important examples are lipid peroxidation and protein damage, 
e.g, addition of carbonyl groups. Carbonyl derivatives of amino acid residues render the 
protein susceptible to proteolysis. From interaction with free radicals, DNA may also 
suffer changes, namely damage (see 2.3). These can be all symptomatic effects for 
numerous diseases such as: cancer, cardiovascular, diabetes, atherosclerosis, neurological 
disorders (Alzheimer's disease and Parkinson's disease) and chronic inflammation, among 
others. Oxidative species can also lead to apoptosis by the activations of the intrinsic 
pathway (34). Lipid peroxidation products [e.g., malondialdehyde (MDA), 4-
hydroxynonenal (HNE)] are potent mutagens and have been reported as modulators of 
signal pathways related to proliferation and apoptosis, processes implicated in 
carcinogenesis (35) 
 The hydroxyl radical, the most potent oxidant known, has an extremely short half-
life, and the capability to attack most biological molecules resulting in the propagation of 
free radical chain reactions. It can be generated through a variety of mechanisms. Ionising 
radiation, which causes decomposition of H2O, resulting in the formation of 
•
OH and 
hydrogen atoms, is also generated by photolytic decomposition of alkylhydroperoxides, or 
by Fenton chemistry using metal as reducing agents. The metal-catalyzed breakdown of 
hydrogen peroxide, according to the general Fenton reaction (see equation 1, where M
n+
 is 
a metal) occurs when M
n+
 is Fe, Cu or Cr. Although other metal can catalyze this reaction, 
these are the most prevalent catalyzers 
               
             . 
  Superoxide anion is formed when oxygen accepts an electron. Superoxide anion 
can act as a reducing agent of iron complexes (e.g., cytochrome c) by the Waber-Weiss 
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reaction and it is likely to be an important source of hydroxyl radicals and hydrogen 
peroxide (23,36). On the other hand, the redox inactive metals, such as Cd, arsenic (As) 
and lead (Pb) can promote oxidative stress indirectly, either by alteration of signaling 
pathways or disrupting anti-oxidant homeostasis. Indeed recent notes describe the direct 
formation of H2O2
 
by arsenic under physiological condition and depletion of glutathione 
reduced by Cd (for review see Jomova 2011 (13)). 
2.2. Anti-Oxidant Defenses 
Antioxidant is any substance that when present at low concentrations (compared with those 
of the oxidizable substrate) considerably delays or inhibits its oxidation (33). Cell 
antioxidative defense can be categorized as enzymatic, non-enzymatic and extracellular 
mechanisms. The enzymatic defense is mediated by a group of enzymes which are capable 
of metabolize ROS and ROS precursors (e.g. H2O2). In the same way, non-enzymatic 
defenses are responsible for an identical process, but without the aid of enzymes, instead, 
are used several molecules that can donate electrons to radical species or by processes who 
diminish ROS production (33, 37, 38).  
2.2.1. Enzymatic defenses 
Cellular antioxidant defenses include the superoxide dismutase (SOD), glutathione 
peroxidase (GPx), and catalase (CAT) enzymes (33). These enzymes act in chain to 
achieve the scavenger of free radicals. SOD isoforms are differently distributed among 
intra and extra cellular spaces. These isoenzymes are capable of catalyzing the dismutation 
of superoxide anion to hydrogen peroxide and molecular oxygen (equation 9)(39). 
         
     
   
             
 
 
Although, H2O2 is a weaker oxidant than superoxide anion it is relatively stable and can 
easily diffuse across biological membranes entering in cellular compartments. Two 
enzymes can breakdown H2O2, GPx and CAT. The first is present in cytosol and 
mitochondria, and has a major role in the breakdown of most H2O2 generated by SOD. In 
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the reduction of H2O2, as illustrated by equation 3, GPx uses as antioxidant the reduced 
glutathione (GSH) generating H2O and oxidized glutathione (GSSG)(40). 
               
   
               
 
CAT can also breakdown H2O2 to molecular oxygen. It is localized in the peroxisomes, 
and is mostly responsible for the removal of H2O2 when it is present in higher 
concentration in tissue (equation 4) (41). 
         
   
           
 
When these enzymatic systems work together, they efficiently maintain the counterbalance 
oxidant species in cells and tissues.  
2.2.2. Non-enzymatic defenses 
 Cells contain non-enzymatic systems capable of contain free radicals insults. 
Molecules such as vitamin E, coenzyme Q, β-carotene and other carotenes are present 
within cell membranes. Also vitamin C (L-ascorbic acid) and GSH are molecules present 
in cytosol (38). These non-enzymatic molecules act as antioxidants and can sustain 
oxidative stress. Furthermore, tissues are also protected against free radicals by several 
binding proteins (transferrin, lactoferrin, ceruloplasmin, haptoglobins, hemopexin and 
albumin) which can sequester metals and keep it in a nonreactive state (23). Indeed the 
mechanism of metal-induced free radicals formation is tightly influenced by the action of 
cellular antioxidants. These proteins are highly inducible by metals and oxidants and thus, 
are critical in protection against exogenous oxidants, as is the case of Cd (42). Moreover, 
many low-molecular weight antioxidants such as ascorbic acid, alpha-tocopherol, 
glutathione (GSH), carotenoids, flavonoids, and other antioxidants, are capable of 
chelating metal ions reducing thus their catalytic activity to form ROS (13). 
2.2.3. Others defenses 
 Besides the above reported antioxidative systems, cells evolved complementary 
mechanisms to regulate ROS production, namely the metabolic uncoupling of 
mitochondria. The short-cut of the mitochondrial electron chain by uncoupling proteins 
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(UCP) decrease the ROS formation where the reduction power of oxidative metabolism is 
transferred to heath production and ROS-formation control (42).  
2.3. Oxidative Damage to Biomolecules 
2.3.1. DNA damage 
 Reactive oxygen species are formed through a variety of events and pathways and 
can react with almost every molecule in cell. The hydroxyl radical is known to directly 
react with all components of the DNA molecule. It can damage purine and pyrimidine 
bases and also the deoxyribose backbone (43). Permanent modification of genetic material 
represents the first step involved in mutagenesis, carcinogenesis and ageing. In fact, is well 
established, in various cancer tissues that free radical-mediated DNA damage had 
occurred. ROS-induced DNA damage can involve single- or double stranded DNA breaks, 
purine, pyrimidine, or deoxyribose modifications, and DNA cross-links. DNA damage can 
result either in arrest or induction of transcription, induction of signal transduction 
pathways, replication errors and genomic instability, all associated to carcinogenesis (44). 
A good biomarker for DNA oxidative stress and a potential biomarker of carcinogenesis is 
8-hydroxyguanine (8-OH-G or 8-oxo-G). This oxidized DNA product is important because 
it is easily produced and also is mutagenic and carcinogenic. Several studies have reported 
8-OH-G link with oxidative damage (45). Other methods for measuring oxidative DNA 
damage may involve for example, enzymatic digestion of DNA; the acidic hydrolysis of 
DNA (46). 
Mutations and altered expression in mitochondrial genes encoding for respiratory 
complexes, and in the hypervariable regions of mtDNA were also identified in several 
cancers (47). mtDNA is close ROS formation, is not protect by histones and has limited 
repairing capability, for all of that it is an easy target to ROS (48). 
2.3.2. Lipid peroxidation 
 All cellular membranes are sensitive to oxidative attack namely those membranes 
with polyunsaturated fatty acids (PUFA) in its composition. The process of lipid 
peroxidation consists of three stages: initiation, propagation and termination. The peroxyl 
radicals (ROO•) after formation can be arranged via a cyclization reaction to 
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endoperoxides with the final product of the peroxidation process being malondialdehyde 
(MDA) (49). The major aldehyde product of lipid peroxidation other than malondialdehyde 
is 4-hydroxy-2-nonenal (HNE). MDA is mutagenic in bacterial and mammalian cells and 
carcinogenic in rats (50). HNE is weakly mutagenic but is the major toxic product of lipid 
peroxidation. It also has a powerful effect on signal transduction pathways. Moreover, lipid 
peroxidation products can interact with DNA, creating adducts that can lead to DNA–DNA 
interstrand crosslinks or DNA–protein crosslinks (50). MDA also exerts direct 
modifications on DNA strands. All of these modifications can be deleterious to cells either 
being genotoxic or carcinogenic. (23). 
2.3.3. Protein oxidation 
 Proteins can also be a target for ROS oxidation. In vivo this is achieved in the 
presence of transition metals capable of entering in Fenton reactions (equation 1). Metal-
catalyzed damages of proteins involve oxidative scission, loss of histidine residues, 
bityrosine crosslinks and introduction of carbonyl groups (51). 
 The hydroxyl radical has the ability to remove hydrogen atom from the protein 
polypeptide backbone forming a carbon centered radical, which can readily react with 
molecular oxygen to form peroxyl radicals (52). Protein damage is likely to be repairable 
and is a known non-lethal event for a cell. The side chains of all amino acid residues of 
proteins are susceptible to oxidation by ionising radiation and by the action of ROS/RNS. 
However, proline, histidine, arginine, lysine and cysteine residues are sensitive to 
oxidation by redox metals and may be preferable protein sites of metal binding. This 
protein-iron complex can react with H2O2, forming hydroxyl radical on site which can 
rapidly promote oxidation process (53) 
 Nitrosylation reactions can also attack proteins. The reaction of nitric oxide with 
superoxide radical results in the formation of the highly toxic peroxinitrite anion which can 
nitrosate cystein, nitrate tyrosine and tryptophan and oxidize methionine to methionine 
sulphoxide. However, the process of modification of proteins by peroxynitrite is strongly 
inhibited by physiological concentration of carbon dioxide (23). Even though the nitration 
of tyrosine is a irreversible process, and can interact in phosphorylation and adenylylation 
process which are important in regulatory pathways (23).  
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 The accumulation of oxidized proteins in living systems can be induced by several 
factors acting isolately or in combination. As consequence of these protein- ROS 
interactions, inter- and intra-protein cross-linkages occur. Moreover, protein carbonyl 
groups are generated. The concentration of protein carbonyl groups is considered a good 
biomarker of ROS mediated protein oxidation. 
2.4. ROS and Cancer 
 Carcinogenesis is a complex multi-sequence process of cell conversion from a 
healthy stage to pre-cancerous and, later, cancer stages. Moreover, the process of 
carcinogenesis consists of multiple distinctive stages, each one characterized by different 
underlying mechanisms. The “initiation–promotion–progression” model of carcinogenesis 
mechanism is based on the equilibrium between cell proliferation and cell death (22). Cell 
proliferation is upregulated by protein p53 which plays a primordial role in it, its checks 
the DNA integrity during cell cycle (54), and triggers mechanisms of DNA repair, for 
instance to eliminate the oxidized DNA bases that cause mutations. Moreover, at the same 
time if the cell damage is too great, it can also trigger cell death by apoptosis. So, there is a 
subtle regulatory system consisting of pro-apoptotic and anti-apoptotic factors controlling 
cell fate. Cancer development is characterized by cumulative action of multiple events 
occurring in a single cell and can be described by the three stages: initiation, promotion 
and progression. ROS can act in all these stages of carcinogenesis through modifications 
on transductions or signaling pathways and also on cellular events. Similarly, several 
chemicals may act as carcinogens by having genotoxic effects or by non-DNA or indirect-
DNA mechanisms.  
 ROS can interact with DNA in the initiation process, causing non-lethal mutation 
that can pass cell cycle checkpoints. The dual role of oxidative stress is expressive in both 
pathways involving cell-cycle and apoptosis deregulation. Although excess of oxidative 
stress can be cytotoxic and halt cell proliferation and induce apoptosis or necrosis, small 
increments can promote cell proliferation inducing tumor growth. Many tumor promoters 
have an inhibiting effect on cellular antioxidant defenses (55). Furthermore, ROS and 
several metal can promote abnormalities in growth factor receptors, and by is one or acting 
through other systems alter Ca
2+
 homeostasis, leading to deregulation of many signaling 
pathways that controls cell proliferation or apoptosis (55).  
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 The stage of tumor progression involves cellular and molecular changes and is 
characterized by accumulation of additional genetic damage, leading to the transition of the 
cell from benign to malignant. One characteristic of this stage is the angiogenesis, which 
promotes the blood supply to tumor cells. Moreover, ROS implicated in tumor 
angiogenesis and may regulate tumor invasiveness by modulating the expression (42, 56, 
57). 
2.4.1. Cadmium, ROS and apoptosis  
 By the above exposed it is highly probable that ROS-inducing chemicals may also 
modulate cell events, in particular cell cycle and apoptosis, traditionally dysfunctional in 
tumor cells (58). Cd does not per se form free radicals directly, but cells exposed to Cd
2+
 
clearly show elevated levels of ROS (59). Some explanations may relay on the fact that Cd 
is highly reactive to protein thiols, depleting the antioxidant cell battery. So, Cd can induce 
responses leading to oxidative stress, but it is still unknown how Cd affects the apoptosis 
pathways. Apoptosis is currently evaluated by the Annexin V. This method is based on a 
property of protein localized predominantly in the inner side of the membrane, the 
phosphatidylserine, which during the first stages of apoptosis is exposed to the outer side. 
Other methods such as TUNEL, caspases expression may also be used (60-62), but this 
will not be subject of this dissertation. 
3. CADMIUM AND OSTEOBLAST METABOLISM 
 Bone tissue, is the major structural and supportive connective tissue of the body 
forming the body skeleton. Furthermore, the bone matrix is formed by the mineralization 
of several elements, namely calcium, magnesium and phosphate in a matrix of type-I 
collagen, which form hydroxyhapatite. This forms a rigid but flexible tissue capable of 
support mechanical charges and by that support the entire body. In addition, it can protect 
vital organs (e.g., brain, heart and lungs) and it is also important in the body movement and 
locomotion.  
 Although is rigid and mineral composition, bone is a dynamic tissue capable of 
remodeling. Osteoblasts are the cells responsible for the formation of bone; they synthesize 
all the constituents of the bone matrix and direct its subsequent mineralization. Once a 
phase of active bone formation is completed the osteoblasts do not become senescent, but 
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instead re-differentiate into one of two major cell types: osteocytes and osteoclasts. Both 
play a major role in the regulation of calcium homeostasis and bone remodeling. 
Moreover, because bone mass is maintained constant by the balance between osteoclastic 
bone resorption and osteoblastic bone formation, alterations in osteoblast proliferation and 
differentiation may disturb the equilibrium of bone remodeling and calcium homeostasis 
(63,64). 
 Furthermore, exposure to Cd has been associated with the alteration of bone 
metabolism and the development of osteoporosis among other alterations. Little 
information is available reporting the Cd accumulation and direct/indirect effects on 
osteoblast cells. Clarification of Cd induced cytotoxicity in osteoblasts will therefore 
contribute to better understand diseases promoted by Cd intoxication like osteoporosis (65) 
or, in particular, tumor (58, 66).  
3.1. Osteoblast in vitro Culture 
 Osteoblasts are central to the process of bone remodeling and are involved in many 
bone diseases. Primary osteoblasts obtained directly from patients are the idyllic cells to in 
vitro studies. However, the use of primary osteoblasts in vitro is limited because of 
difficulty in obtaining sufficient bone fragments for harvesting cells. Furthermore, primary 
osteoblasts are difficult to culture in vitro, have a finite life-span and also can lose their 
phenotype as the number of passages increases (67).  
 One way to bypass that problem is to study osteosarcoma-derived cell lines which 
are highly proliferative. Moreover, cell lines derived from human cancers have been 
crucial to building our understanding of the molecular pathophysiology of cancer and its 
treatment, and have been routinely used as a model for osteoblasts to characterize their 
interaction with various biomaterials and are widely used in cytotoxic studies. Equally, 
they form an in vitro model system for rational drug discovery and development because 
they are easy to maintain and manipulate in vitro and in animal models (68). 
 Many osteoblast-like cell lines have been developed. Osteosarcoma derived cell 
lines are relatively easy to culture and have a high rate of proliferation and long life-span. 
The MG-63 osteoblast-like cells line used in this study was originally isolated from a 
human osteosarcoma. MG-63 cell line is relatively immature osteoblasts that have been 
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well characterized, it presents an anomalous karyotype, with multiple triploidy, however 
they show several similarities with isolated human bone-derived cells (69, 72). Indeed, 
they are widely used for testing biomaterials and in toxicological screening (70, 71). 
Moreover, MG-63 cells present biomarkers exclusive of human osteoblasts, including 
alkaline phosphatase, bone sialoprotein, osteonectin, osteopontin, and growth factors (e.g., 
bone morphogenetic protein). Altogether, MG-63 cells are suitable to serve as a model of 
human osteoblast cells (69,73). 
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Objectives 
 The main aim of the present dissertation was to evaluate putative cytotoxic effects 
of Cd in bone cells. As described in the introduction, a particularly sensitive cascade in the 
cell is the one involving oxidative stress unbalances. This issue still remains fuzzy in what 
concerns Cd-cell interactions. A complete elucidation of oxidative stress deregulation by 
Cd will help in deciphering later and depended mechanisms such as apoptosis and cell 
cycle, and ultimately aspects related with carcinogenesis. 
 To achieve this, it was used the cell line MG-63, a line with rapid growth and 
retaining osteoblast like characteristics, and one of the most widely used cell lines in these 
kind of assays in bone studies in vitro.  
 These cells were exposed to increasing concentrations of Cd, and some of the most 
important enzymes of oxidative stress were measured. Also Cd-induced apoptosis was 
evaluated by annexinV. An integrated analyse of these responses will provide a more 
complete insight of the effects of Cd in osteoblasts. 
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Material and Methods 
4. MATERIAL 
 The cell line MG-63 was courtesy of INEB (Instituto de Engenharia Biomédica-
Porto, Portugal). GIBCO
® 
Culture medium α-MEM GlutaMAX™, Trypsin-EDTA 0.25%, 
Fungizone and Peniciline/Streptomicine were purchased from Life Technologies 
(Carlsbad, US-CA). SOD Assay Kit and Total Glutathione Assay Kit were obtained from 
Sigma-Aldrich (St. Louis, US-MO). BD Pharmingen™ Annexin V: FITC Apoptosis 
Detection Kit was bought to Bencton Dickinson and Company (Franklin Lakes, US-NJ).  
 All other reagents were purchased from Sigma-Aldrich (St. Louis, US-MO) at 
highest grade available. All solutions were prepared using ultrapure water obtained in a 
MILI-Q System from Millipore (Billerica, US-MA). 
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5. METHODS 
5.1. Cell Culture 
 The MG-63 cell line was cultured in α-MEM GlutaMAX™ medium and incubated 
with controlled atmosphere at 37 °C and 5% CO2. Cells were subcultured once a week. 
The cell culture was maintained in 75 cm
2
 standard culture flasks and the medium 
consisted of 10 ml of  α-Minimal Essential Medium with GlutaMAX™ (α-MEM) 
supplemented with 10% (v/v) of Fetal Bovine Serum (FBS), 100 U/mL of 
Peniciline/Streptomicine and 2.50 µg/mL of Fungizone (final concentrations). The 
passages were done before the cells reach full confluence. 
5.1.1. Harvesting cells 
 The standard process for cell harvesting was performed by addition of trypsine, a 
proteolitic enzyme. Cells were first washed twice with Phosphate Buffer Saline without 
Ca
2+
/Mg
2+ 
(PBS), and then incubated with trypsine (1 mL/25 cm
2
) for 5-10 min at 37 °C. 
When cells were detached, the trypsine was deactivated with growth medium with FBS 
and the cells were resuspended to be counted by using a hemocytometer. For subculture 
procedure, cells were seeded at 10
5
 cell/mL in 10 mL of supplemented medium.    
5.1.2. Cell exposure 
 All assays were performed within twenty passages from defrosting. For all the 
assays the procedure to exposure remains mostly the same. Mainly, cells were plated and 
left 24 hours to adhere and when the cells reached 50-60% of confluence, the seeding 
medium was then removed and substituted by cadmium chloride dissolved in 
supplemented medium at final concentrations of 20 and 50 μM. Cells were left to growth 
for 24 and 48 hours and then harvested. Depending of the particular assay cells undergone 
slightly different seeding and harvesting methods. 
5.2. Protein Quantification 
 The Bradford assay, is a colorimetric method to quantify the protein content of 
samples. This method is based in the binding of the dye Coomassie Brilliant Blue G-250 
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(Bradford Reagent) to protein which causes a shift in it absorption from 465 nm to 595 nm, 
the amount of absorption is proportional to the quantity of protein (74). 
 In brief, 5 μL of each cell extract was incubated in 250 μL of Bradford Reagent left 
to incubate in dark for 10 min and then the absorbance read at 595 nm in a microplate 
reader (Synergy HT from BioTek
®
). Concentrations of unknown samples were 
extrapolated from a standard curve performed with known concentration of bovine serum 
albumin (BSA). 
5.3. Cell Viability  
 Cell viability was measured by the MTT assay as described by Twentyman (75) 
with some modifications. MTT assay relies on the capability of viable cells to reduce a 
tetrazolium salt (3-(4, 5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide-MTT) to an 
intercellular purple formazan which can be solubilized and quantified 
spectrophotometrically. The signal produced is linear to the quantity of viable cells. 
 To verify the interaction of Cd on cell viability, cells were seeded in a 96 well plate 
at the concentration of 10
5
 cells/mL. Cells were left 24 hours to adhere and then were 
exposed to 20 and 50 µM of Cd in growth medium. After time exposure (24/48 hours), 
cells were incubated with 50 µL of MTT (1 mg/mL in sterile PBS) for 4 hours at 37 °C. 
The medium was removed and 150 μL of DMSO (Dimethyl sulfoxide) were added, then 
cells were stirred in dark for two hours in order to dissolve all formazan crystals. After this 
time, at the absorbance for each well was measured at 570 nm with a microplate reader 
(Synergy™ HT Multi-Mode from BioTeK®). The data was expressed by the ratio of 
absorbance between exposed and non-exposed cells in percentage. 
5.4. Enzymatic Parameters 
 To assay all enzymes, cells were seeded in 100 mm Corning
®
 culture dishes and 
exposed to Cd as described above in 5.1.2. To prepare homogenates the method described 
by Quick (76) was followed with some modification. Briefly, the culture medium was 
removed and 2 mL of cold phosphate buffer (5 mM, pH 7.4) with 0.5 mM of EDTA was 
added and cells were frozen to disrupt membranes. After thawing, the cultures were 
scraped and sonicated 3 times for 30s over ice. Finally, to clear cellular debris the 
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homogenates were centrifuged at 12,000 xg for 15 min at 4 °C. The pellet was discarded 
and the supernatants were aliquoted to separated vials, one for each enzyme and other for 
protein quantification. All samples were stored at -80 °C until assayed.       
5.4.1. Superoxide Dismutase 
 Superoxide Dismutase (SOD) catalyzes the dismutation of superoxide anion O2
•- 
to 
molecular
 
oxygen and oxygen peroxide (H2O2). At present, three distinct isoforms of SOD 
have been identified in mammals, CuZn-SOD, Mn-SOD and EC-SOD which differ in their 
structure and location. They are the first line of defense against oxidative stress namely by 
acting as a superoxide anion radical scavenger (39). 
 Total SOD activity was measured by using Sigma-Aldrich
®
 SOD-assay kit. This kit 
uses a coupled reaction in which SOD competes with xantine oxidase (XO) by the 
superoxide anion in the reduction of a water soluble tetrazolium salt, WST-1 (2-(4-
Iodophenyl)- 3-(4-nitrophenyl)-5-(2,4-disulfophenyl)- 2H-tetrazolium,monosodium salt). 
The reaction was performed in accordance to kit instructions. It consisted of the addition of 
20 μL of sample to 200 μL of a buffer with WST-1. The reaction started with the addition 
of 20 μL of xantine-oxidase (XO) solution. The reaction was carried out in a 96 well plate, 
and the absorbance variation was read in a microplate reader (Synergy™ HT Multi-Mode 
from BioTeK®) in kinetic mode at 440 nm for 5 min. The percentage of inhibition was 
calculated by the following equation: 
                        
               
       
     
 
 The reaction was always performed with a “blank well” to calculate xantine-
oxidase maximum rate (S1). Several other “blank wells” were attributed to account with 
non specific reduction of WST-1 and other sources of superoxide anion, namely a well 
without XO and sample (S3), and other only without XO (S2). All results were normalized 
by samples protein concentration and one unit of SOD activity was considered as the 
quantity of enzyme which gives a 50% inhibition of the reduction of WST-1.  
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5.4.2. Catalase 
 Catalase exerts a dual function on cell physiology, a catalytic function with the 
decomposition of hydrogen peroxide (H2O2) to water and molecular oxygen and a 
peroxidic activity, oxidation of hydrogen donors like methanol and ethanol (41, 47) 
 Catalase activity was directly measured by the decay in absorbance of H2O2 at 240 
nm. The difference in absorbance at 240 nm per unit of time is the measure of its activity. 
This assay was performed accordingly to Aebi (41) with few modifications. The reaction 
was carried out in a 1.5 mL quartz cuvette at 25 °C. The reaction started with the addition 
of H2O2 (12,5 mM final concentration) to 50 μL of sample in 50 mM phosphate buffer pH 
7.0 all mixed by inversion. The absorbance reading was taken against a “Blank” composed 
of only buffer with sample. The absorbance decay was followed and one unit of catalase 
activity was expressed by the number of nmoles of H2O2 consumed per minute (41). 
5.4.3. Glutathione Reductase 
 GR plays an important role in cell antioxidant state by producing antioxidant 
species. GR catalyzes the reduction of glutathione disulfide (GSSG) produced by GPx 
activity, to the glutathione reduced form (GSH) using NAPDH as its source of reducing 
equivalents. GSH reduced power can again be used by glutathione peroxidase (GPx) in 
reduction of peroxides. These reaction produce GSSG which is then recycled to GSH by 
GR (Equation 6). 
                   
             
                 
 
 GR activity was measured directly by the decay in absorbance of NADPH at 340 
nm in a microplate reader accordingly to Dringen (77) with slightly modifications. The 
reaction was carried in a phosphate buffer 100 mM with EDTA 1 mM at 7.0 pH and 25 °C. 
The reaction was started by the addition of GSSG solution in 1:1 to the mixture of NADPH 
and sample in a 96 wells microplate plate. The final concentrations were GSSG 1 mM and 
0.2 mM of NADPH in a final volume of 320 μL. In parallel with samples measurements, it 
was performed a calibration curve with standard GR to extrapolate the sample activity. 
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Finally, the GR’s specific activity was expressed as a ratio of its activity and the protein 
content of the samples. 
5.4.4. Total Glutathione quantification 
 Glutathione as been described earlier have an important role in antioxidant status. 
Briefly GSH serves as a co-substrate to glutathione transferase in xenobiotics 
detoxification and as an electron donor to GPx having an antioxidant role (78). 
 The quantification of total glutathione was done with The Glutathione Assay Kit 
from Sigma-Aldrich
®
. This utilizes an enzymatic recycling method, which uses glutathione 
reductase to quantify GSH/GSSG content of the sample. This method relies on the 
capability of DTNB (5.5'-dithio-bis-2-nitrobenzoic acid or Ellman’s reagent) to react with 
GSH producing a yellow compound, 5-thio-2-nitrobenzoic acid (TNB). GR recycles the 
glutathione which is then reused in the reaction. The rate of TNB production is directly 
proportional to this recycling reaction which in turn is directly proportional to the 
concentration of GSH in the sample. The TNB formation is followed at 412 nm, and the 
total glutathione content is extrapolated with the aid of a calibration curve with known 
GSH concentrations. 
 For this assay, kit instructions were followed. Briefly cells were seeded in 150 mm 
Corning
®
 culture dishes in order to achieve the harvest of at least 10
6
 cells. Cd exposure 
was performed was described in 5.1.2. Cells were harvested by scrapping from plates in 
PBS buffer and concentrated by centrifugation at 600 xg. The supernatant was discarded 
and added 3 volumes of 5% SSA (5-Sulfosalicylic Acid) after homogenization two freeze 
and thaw cycles were performed. Finally the homogenates centrifuged at 10000 x g for 10 
min at 4 °C, to clear cellular debris, pellets were discarded and total glutathione content 
were measured in supernatant. To quantify glutathione content, 10 μL of each sample were 
added to one well of a 96 well plate in triplicate, followed by the addition of a buffer 
containing DTNB, GR and finally to start the reaction a NADPH solution (all supplied by 
the Kit). The reactions were measured in kinetic mode at 412 nm in a multiplate reader 
(Synergy™ HT Multi-Mode from BioTeK®). Glutathione concentrations of all samples 
were extrapolated from a standard curve with known concentrations of reduced glutathione 
diluted in 5% SSA performed at same time of the assay. 
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5.5. Apoptose 
5.5.1. Annexin V assay 
 Apoptosis or programmed cell death is a normal physiologic process. The apoptotic 
program is characterized by morphologic features, including loss of plasma membrane 
asymmetry and attachment, nucleus condensation, and cleavage of DNA. Loss of plasma 
membrane is one of the earliest features. In apoptotic cells, the membrane phospholipid 
phosphatidylserine (PS) is translocated from the inner to the outer leaflet of the plasma 
membrane, exposing PS externally. 
 Annexin V is a phospholipid-binding protein that has a high affinity for PS. In this 
assay Annexin V is used conjugated with fluorescein isothiocyanate (FITC) as a sensitive 
probe to PS. The cells which are undergoing apoptosis can then be access by flow 
cytometry. Since externalization of PS occurs in the earlier stages of apoptosis, FITC 
Annexin V staining can identify apoptosis at an earlier stage than other assays, namely, 
those based on nuclear changes. 
 Apoptosis was measured by flow cytometry using FITC Annexin V Apoptosis 
Detection Kit from BD Pharmingem™. Briefly this kit uses a double staining with 
Annexin V-FITC and propidium iodide (PI). The double staining with PI, which is 
excluded by intact plasma membranes, allows the differentiation of early apoptotic 
(Annexin V-FITC positive/PI negative cells) from late apoptotic (Annexin V-FITC 
positive/PI positive). 
 For this assay cells were harvested with trypsine and centrifuged at 300x g twice in 
cold PBS. Finally cells were resuspended in “1x binding buffer” at 105 cells/mL, 100 μL of 
sample was used and added 5 μL of FITC-Annexin V and PI to each sample. Samples were 
then left in dark for 15 min, and after this time 400 μL of “1x Binding Buffer” was added 
and samples analyzed by flow cytometry. 
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5.6. Data and Statistical Analysis  
 For all assays were performed at least three independent experiments. The 
statistical analysis was performed in the software SigmaPlot version 11. All analysis of 
variance were performed with one-way ANOVA, followed by Holm-Sidak to test 
differences between groups and the control exposure. It was considered that results are 
statistically significant when p<0.05. All data is expressed as mean ± standard deviation 
(SD) from mean. 
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Results  
6. GLOBAL SCREENING OF CELL CULTURES EXPOSED TO CADMIUM 
 Control MG-63 cells presented a good proliferation, with total confluence being 
achieved after 4 days. At the inverted microscope (Nikon
®
 Eclipse TS100), cells had 
typical fibroblastic aspect. Cultures treated with Cd showed some morphological changes 
such as cell enlargement, and loss of adherence. The cell confluence for all Cd exposures 
was less than the observed in control. In the highest concentration it could also be seen 
frequently floating cells (see Figure 1)  
  
 
Figure 1-General appearance of MG-63 cell line after Cd exposure. a-b-c- 24 hours exposures, control, 20 and 50 µM respectively; d-e-f- 48 hours exposures, control, 
20 and 50 µM respectively 
40 x 40 x 40 x 
40 x 
40 x 40 x 
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7. VIABILITY ASSAY 
 The MTT assay was used to asses if Cd could modify cell viability of MG-63 cell 
line. Data show that Cd induced a dose-response inhibition of cell viability of MG-63 cell 
line at both times (Figure 2 and Figure 3). At low Cd concentrations of Cd, it was observed 
a small trend to stimulate cell viability (hormesis effect) despite not significant (Figure 2 
and Figure 3). Inhibition  
 
 
Figure 3-MTT assay for 48 hours. Data expressed as a percentage of control. Values from 5 
independent experiments ± SD 
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Figure 2- MTT assay for 24 hours. Data expressed as a percentage of control. Values from 5 
independent experiments ± SD 
 
Viability Assay 24 hours
Cadmium Concentration in M
0 20 40 60 80 100 120 140 160
V
ia
b
il
it
y
 I
n
h
ib
it
io
n
 i
n
 %
-20
0
20
40
60
80
100
 29 
 
 A Pearson correlation demonstrates that the relation between Cd concentration and 
inhibition of cell viability is strong and positive for both periods of the experiment. 
Namely, the coefficient of correlation for 24 hours is 0.919 (p<0.0001), and for 48 hours is 
0.891 (p<0.0001). With this strong correlation, the concentration of Cd that reduces in half 
the viability of MG-63, the lethal dose (LD50), could be calculated for both times. Thus, the 
LD50 for Cd exposure in MG-63 cell line is 91 µM, for 24 hours and 64 μM for 48 hours. 
Based on these results, we chose the sublethal doses of Cd, 20 and 50 μM, for further 
studies. 
8. ENZYMATIC ASSAYS 
8.1. Superoxide dismutase activity 
 The SOD activity shows an increasing trend, with Cd concentration, after 24 and 48 
hours (Figure 4). For the 24 hours exposure those differences are not significantly different 
but have a slight increase. SOD activity at 48 hours shown the same trend with a 
significant increase for the 50 μM concentration (Figure 4). 
  
 
Figure 4-SOD activity for both times expressed as a percentage of control. Values from 4 independent 
experiments ± SD. * p<0.05 
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8.2. Catalase activity 
 CAT activity shows an increasing trend with Cd concentration. Moreover, CAT 
activity at 24 hours for 50 µM Cd concentration had a significant increase of almost 8 fold. 
To the 20 μM CAT activity also in 2 fold from control but without statistical significance 
(Figure 5 – 24 hours). The 48 hours exposure showed the same trend of 24 hours with a 
continuous and significant increase of near 2 folds of CAT activity for all Cd doses (Figure 
5- 48 hours).  
8.3. Glutathione Reductase 
 Cd exposure to MG-63 cell line has a global interaction with GR. The decrease in 
GR activity is evident in both times. Indeed, both doses led to results significantly different 
from those of the control. However, only at 24 hours, there was a significant difference 
(p<0.05) among the exposed groups. The observed decrease of GR activity after 48h was 
not statistically significant (Figure 6). 
 
Figure 5 CAT activity for 24 and 48 hours expressed as a percentage of control. Values from 4 
independent experiments ± SD (* p<0.05 and ** p<0.001) 
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8.4. Total glutathione content 
 Cd alters significantly total glutathione content in 24 hours exposure. At this time, 
both concentrations decrease almost in half its glutathione content (Figure 7-24 hours). 
However, for the 48 hours exposure there are no differences between control and Cd 
exposures respecting the glutathione concentration. At this time point, a significant 
decrease in glutathione concentration was detected in controls between both times (t-test; 
p<0.001- Figure 7). 
 
Figure 6-GR activity expressed as percentage of control. Values from 3 independent experiments 
and expressed in percentage from controls ± SD (* p<0.05) 
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Figure 7-Concentration of glutathione for 24 and 48 hours expressed as a percentage of control. Values from 
4 independent experiments ± SD (** p<0.001) 
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8.5. Apoptosis assay 
 The results show a significant increase in the early apoptotic event for the 20 µM 
exposure in 24 hours. Moreover, the late apoptosis and live cell count, although not 
significant, show differences for the 50 µM exposure, comparatively to the control (Figure 
8-24 hours). The 48 hours assay shows us also a difference in apoptosis between 
conditions. Cd at the highest concentration (50 µM) was significant different from control. 
Indeed, this Cd concentration increased the number of cells in early and late apoptosis and 
a decrease in live cell number. For the 20 µM exposure, Cd also increased the number of 
cells undergoing early apoptosis (Figure 8-48 hours).  
 
Figure 8-Annexin V-FITC assay for apoptosis assessment. Results for  24 and 48 hours exposures. 
Values from 4 independent experiments ± SD (* p<0.05 and ** p<0.001) 
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Discussion 
 Cd exposure is known to cause disturbances on cell free radicals homeostasis. This 
is mainly accomplished by disruption of oxidative defenses (13, 22, 30). In MG-63 cell 
line data of cell viability shows that Cd can induce cell death in a dose-dependent manner 
and, as expected, this response increases with time exposure. These gradual and time 
dependent effects quantitatively supported the visual analyses (qualitative) in which 
cultures with Cd shown a decrease in confluence and a general augmentation in cells 
detached from the plate (figure 1). In general the data obtained in this dissertation for Cd-
induced cell viability is supported by other authors, but a survey of literature shows a 
strong dependence of genotype/linage in Cd-induced death (79). Indeed, recent studies 
shown that rat C6 glial cells showed high sensitivity to Cd (20 μM) while the human 
keratinocytes HaCaT demonstrated high tolerance both reviewed by Nzengue (62).  
 The small increment in cell viability at very small Cd concentrations supports a 
putative hormesis effect of Cd. This effect may be justified by a small increment in, ROS 
levels, which are known to induce cell proliferation (26, 58). Another possible explanation 
may relay on the possible inhibition of apoptosis regulating proteins (54, 80).  
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 From these results a Cd sublethal dose was chosen to better assess the small 
changes in cell oxidant defenses. Those doses were chosen to assess small Cd induced 
alteration before antioxidant defenses are completely overwhelmed, thus allowing us a 
small scope in Cd-induced alterations. Therefore, Cd concentrations chosen were 20 and 
50 μM, both sublethal (< 61 μM at 48 hours). 
 One of the first lines of antioxidant defenses are the enzymatic antioxidant 
defenses. Moreover, small disturbances in this system can immediately lead to oxidative 
stress resulting in several damages to cells (38, 81). The mechanisms by which Cd disrupts 
oxidative defenses are not fully understood yet, and can vary from tissue to tissue or 
among lineages (29, 79). Bone tissue relays on redox signaling to its own metabolism, so it 
is particularly sensitive to alterations on oxidative state (82-84). Indeed the CAT activity 
was highly increased with both doses and at both times of exposure. This suggests that the 
cells exposed are subjected to an increase of oxidative stress, namely a surge of H2O2. 
Although, other studies have concluded that Cd decreases CAT activity (85, 86), this is 
probably due to a different sensitivities in the study model and the Cd concentration used.  
 With CAT augmentation was also expected a parallel increase of SOD activity. 
Despite that, SOD activity only shows a slight increasing trend without statistical 
significance, with the exception for 48 hours and for the highest Cd concentration. 
Although this data seems contradictory, it is supported by other studies which also refer 
this fact (87, 88). That is probably due to Cd displacement of Zn ion in cell and in SOD 
active center, promoting a decrease in its activity (89). Moreover, the data suggests that Cd 
is inducing H2O2 by other sources than SOD. At the same moment Cd also induces 
oxidative stress by the displacement of Fe, which can produce hydroxyl anion by fenton 
chemistry (90-92). Moreover, CAT activity increase can also increment the presence of 
molecular oxygen which in their turn can be another source of free radical (eg. interactions 
with mitochondria)(13). 
 Another enzyme that can degrade H2O2 is glutathione peroxidase, leading to water 
as final product. This enzyme uses the reductive power of reduced glutathione (GSH), so is 
intimately linked to the GSH/GSSG cellular content. GSH is a low molecular thiol that 
besides being a GPx substract, also may act, alone, as an antioxidant agent, its reported that 
GSH its responsible by almost 80% of total radical scavenging in cell (93). GSH can be 
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produced in the cell by de novo synthesis, but its majority is recycled by GR from its 
dimerized form, GSSG. It has been described that Cd has high affinity to GSH and can 
impair GR activity (11, 30, 93) these results are fully corroborated for the GR activity on 
MG-63 cell line. GR activity significantly decreased in about 38 and 36% in 50 μM and 20 
μM for 24 hours exposure. This significant decrease in GR could result in a significant 
lowering of total antioxidant capability and in an immediate H2O2 increase. In line with 
GR activity, is total glutathione content the small protein thiol which is the substrate of 
glutathione peroxidase, it is significantly depleted mainly at 24 hours. This results was 
been described by other authors in other models (5, 79). This data signifies that Cd is 
acting in at least 2 fronts, it is boosting ROS production and depleting oxidative defenses, 
namely, SOD, glutathione cycle, and GSH content. 
 Our data indicates that Cd also increases cell death by apoptosis. The data from 
Annexin V assay shown that already at 24 hours Cd induces apoptosis. Cd promoted the 
decrease in the number of live cells when compared to control, and a significant increase in 
the cells in early apoptosis (20 μM Cd). Furthermore, data for 48 hours show the same 
trend. In fact, for this time Cd exposed cells shown an apoptosis profile with both 
concentration undergoing early apoptotic events and in the case of 50 μM a significant 
number of cells are in late apoptosis or dead. This may be probably linked to Cd-induced 
ROS, because it is well known that ROS generation is intimately associated with apoptosis 
(94, 95) 
 Altogether, Cd in MG-63 cell line induces apoptosis, which is probably promoted 
by the oxidative stress imbalance. Because Cd does not produce directly free radicals it 
must promote oxidative imbalance in an indirect way, increasing redox metal in cytoplasm 
or disrupting oxidative defenses all of this promote Cd-induced damage.  
 Moreover, our data show that Cd, even at sub-lethal doses, promotes oxidative 
stress. This conjugated with the Cd capability to interact with genomic machinery can in 
long-term result in Cd carcinogenicity as has been reviewed by Valko (23). In fact, the 
hormesis effect, evidenced at very low concentrations (less than 20 μM), is probably the 
key to Cd carcinogenicity. In particular, Cd seems to increase ROS which by its turn can 
promote cellular viability. This increase linked to Cd interaction with genome can in long-
term expositions lead to genotoxicity and eventually to cancer. 
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Conclusions and Future 
Perspectives 
 In conclusion, these results suggest that Cd can induce physiological alteration on 
MG-63 cell line by the disruption of cellular redox state. In particular Cd enhances CAT 
activity, impairs SOD activity, significantly inhibits GR and lowers the glutathione 
content. These alterations finally results in cell death. 
 Based on the results obtained we propose a model for Cd-induced oxidative stress 
on MG-63 cell line. Cd induces an increase on oxidant species and at the same time 
inhibits glutathione cycle. Moreover the CAT increase promotes the molecular oxygen 
increase inside cell. The molecular oxygen can then interact with several molecules or 
organelles (e.g. mitochondria) creating a loop in which the antioxidant enzyme can 
promote superoxide formation. The two factors acting synergically, enhances ROS 
production and lower antioxidant defenses leading to oxidative stress imbalance, and 
finally to cell death via apoptosis (Figure 9). 
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 To fully understand Cd-induced toxicity and complete the proposed model, future 
work should be done. Namely, the GPx specific activity is important to corroborate the Cd 
impairment of the glutathione cycle. Assessment of calcium and iron homeostasis it is 
important to elucidate primary ROS production, as well as other possible Cd targets. 
Moreover, quantification of ROS, either H2O2, superoxide anion or hydroxyl ion. It is also 
important damage assessment, like lipid peroxidation and/or protein carbonyl content. 
Finally, other parameters such as mitochondrial integrity, mitochondrial membrane 
potential, caspases activation, cytocrome c release, among others, could also clarify the 
Cd-induced apoptotic pathway. 
 
 
Figure 9 –Proposed model for Cd-induced oxidative stress on MG-63 cell line 
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